Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Endocrine 1

Conditions

Colorectal Neoplasms 12Breast Neoplasms 10Lung Neoplasms 9Neoplasms 8Uterine Cervical Neoplasms 7Colonic Neoplasms 5Hematopoietic and Lymphatic System Neoplasm 4Papillomavirus Infections 3Liver Neoplasms 3Carcinoma, Hepatocellular 3Rectal Neoplasms 2Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Patient Compliance 2Neoplasm Metastasis 2Hematologic Neoplasms 2Colorectal Cancer Screening 2Tobacco Use 1Smoking 1Pyloric Stenosis, Hypertrophic 1Psychological Well-Being 1Overweight 1Obesity 1Multiple Myeloma 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Liver Diseases 1Hypertension 1Hepatitis C 1Head and Neck Neoplasms 1

Interventions

Nutrition Assessment 4Bevacizumab 2Thiazides 1Resistance Training 1Patient Navigation 1Palliative Care 1Nitroprusside 1Methods 1Lysine Acetyltransferase 5 1Lisinopril 1Hydrochlorothiazide 1Holistic Health 1Food Insecurity 1Exercise 1Educational Status 1Angiotensin-Converting Enzyme Inhibitors 1Adrenalectomy 1Acetylcholine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hypertension × Patient Navigation × Clear all
NCT01092078 2015-04-22

MISTER-B

NYU Langone Health

Phase NA Completed
740 enrolled
EndocrineGastrointestinal

Colonic Neoplasms, Hypertension, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡